Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells

Biology of Reproduction

Volumn 86, Issue 3, 2012, Pages

  Kwintkiewicz, Jakub ^a   Padilla Banks, Elizabeth ^a   Jefferson, Wendy N ^a   Jacobs, Ilana M ^a   Wade, Paul A ^a   Williams, Carmen J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cell cycle; Chromatin; Cohesin; Granulosa cells; Nurd complex; Ovary

Indexed keywords

COHESIN; CYCLIN B1; CYCLIN B2; HISTONE DEACETYLASE 1; HISTONE H3; METASTASIS ASSOCIATED PROTEIN 3; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; COHESINS; HISTONE DEACETYLASE; MTA3 PROTEIN, MOUSE; NONHISTONE PROTEIN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MEMBRANE; CELL NUCLEUS; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GRANULOSA CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; MITOSIS; MOUSE; NEWBORN; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; ANIMAL; ANIMAL MODEL; CELL CULTURE; CELL CYCLE; CELL DIVISION; CYTOLOGY; FEMALE; IN VITRO STUDY; MOUSE STRAIN; PHYSIOLOGY;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN B1; CYCLIN B2; FEMALE; G2 PHASE; GRANULOSA CELLS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; NEOPLASM PROTEINS;

EID: 84860629737     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.096032     Document Type: Article

References (45)

1. Fortune JE. Ovarian follicular growth and development in mammals. Biol Reprod 1994; 50:225-232.
2. Richards JS. Hormonal control of gene expression in the ovary. Endocr Rev 1994; 15:725-751.
3. Richards JS. Perspective: the ovarian follicle: a perspective in 2001. Endocrinology 2001; 142:2184-2193.
4. Lavoie HA, King SR. Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood) 2009; 234:880-907.
5. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010; 463:474-484.
6. Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996; 384:641-643.
7. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87:953-959.
8. LaVoie HA. Epigenetic control of ovarian function: the emerging role of histone modifications. Mol Cell Endocrinol 2005; 243:12-18.
9. Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004; 93:57-67.
10. Lazzaro MA, Pepin D, Pescador N, Murphy BD, Vanderhyden BC, Picketts DJ. The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells. Mol Endocrinol 2006; 20:2406-2417.
11. Nimz M, Spitschak M, Furbass R, Vanselow J. The pre-ovulatory luteinizing hormone surge is followed by down-regulation of CYP19A1, HSD3B1, and CYP17A1 and chromatin condensation of the corresponding promoters in bovine follicles. Mol Reprod Dev 2010; 77:1040-1048.
12. Hiroi H, Christenson LK, Chang L, Sammel MD, Berger SL, Strauss JF III. Temporal and spatial changes in transcription factor binding and histone modifications at the steroidogenic acute regulatory protein (stAR) locus associated with stAR transcription. Mol Endocrinol 2004; 18:791-806.
13. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 2004; 1677:52-57.
14. Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007; 26:5433-5438.
15. Eisen JA, Sweder KS, Hanawalt PC. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 1995; 23:2715-2723.
16. Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS. Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A 1997; 94:11472-11477.
17. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998; 395:917-921.
18. Hakimi MA, Bochar DA, Schmiesing JA, Dong Y, Barak OG, Speicher DW, Yokomori K, Shiekhattar R. A chromatin remodelling complex that loads cohesin onto human chromosomes. Nature 2002; 418:994-998.
19. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, Taatjes DJ, Dekker J, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010; 467:430-435.
20. Polo SE, Kaidi A, Baskcomb L, Galanty Y, Jackson SP. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4. EMBO J 2010; 29:3130-3139.
21. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc Natl Acad Sci U S A 2010; 107:18475-18480.
22. Smeenk G, Wiegant WW, Vrolijk H, Solari AP, Pastink A, van Attikum H. The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage. J Cell Biol 2010; 190:741-749.
23. Larsen DH, Poinsignon C, Gudjonsson T, Dinant C, Payne MR, Hari FJ, Danielsen JM, Menard P, Sand JC, Stucki M, Lukas C, Bartek J, et al. The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage. J Cell Biol 2010; 190:731-740.
24. Li DQ, Pakala SB, Reddy SD, Ohshiro K, Peng SH, Lian Y, Fu SW, Kumar R. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem 2010; 285:10044-10052.
25. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003; 113:207-219.
26. Fujita N, Kajita M, Taysavang P, Wade PA. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 2004; 18:2937-2949.
27. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 2001; 29:.
28. Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Neurosci 2006; Chapter 4:Unit 4.21.
29. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 2004; 119:75-86.
30. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD: a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998; 2:851-861.
31. Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278:42560-42568.
32. Noh EJ, Lim DS, Lee JS. A novel role for methyl CpG-binding domain protein 3, a component of the histone deacetylase complex, in regulation of cell cycle progression and cell death. Biochem Biophys Res Commun 2009; 378:332-337.
33. Noh EJ, Lee JS. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. Biochem Biophys Res Commun 2003; 310:267-273.
34. Xiong B, Gerton JL. Regulators of the cohesin network. Annu Rev Biochem 2010; 79:131-153.
35. Helbling Chadwick L, Chadwick BP, Jaye DL, Wade PA. The Mi-2/ NuRD complex associates with pericentromeric heterochromatin during S phase in rapidly proliferating lymphoid cells. Chromosoma 2009; 118:445-457.
36. Lazzaro MA, Picketts DJ. Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l. J Neurochem 2001; 77:1145-1156.
37. Becker M, Stolz A, Ertych N, Bastians H. Centromere localization of INCENP-aurora B is sufficient to support spindle checkpoint function. Cell Cycle 2010; 9:1360-1372.
38. Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3: what for? J Cell Sci 2003; 116:3677-3685.
39. Ruiz-Cortes ZT, Kimmins S, Monaco L, Burns KH, Sassone-Corsi P, Murphy BD. Estrogen mediates phosphorylation of histone H3 in ovarian follicle and mammary epithelial tumor cells via the mitotic kinase, Aurora B. Mol Endocrinol 2005; 19:2991-3000.
40. Barr AR, Gergely F. Aurora-A: the maker and breaker of spindle poles. J Cell Sci 2007; 120:2987-2996.
41. Pines J, Rieder CL. Re-staging mitosis: a contemporary view of mitotic progression. Nat Cell Biol 2001; 3:E3-E6.
42. Ito M. Factors controlling cyclin B expression. Plant Mol Biol 2000; 43:677-690.
43. Fung TK, Poon RY. A roller coaster ride with the mitotic cyclins. Semin Cell Dev Biol 2005; 16:335-342.
44. Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, Haas BJ, Braisted JC, Kim I, Lee NH, Kumar R. Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Res 2007; 67:7132-7138.
45. Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F, Kumar R. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem 2010; 285:6980-6986.